Clinical Trials Directory

Trials / Completed

CompletedNCT01322464

Study to Assess Food Effect on Sativex Bioavailability

A Phase I Study to Assess the Effect of Food on the Single-Dose Bioavailability of Sativex, and to Compare the Single and Multiple Dose Pharmacokinetics of Sativex at Three Dose Levels

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Jazz Pharmaceuticals · Industry
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Study to assess effect of food on the bioavailability of a single dose of Sativex and to measure its' pharmacokinetics after a single and multiple doses.

Detailed description

This was an open-label, randomised, ascending dose, 2-way crossover food-effect study incorporating a parallel single and multiple dose components in healthy subjects.

Conditions

Interventions

TypeNameDescription
DRUGSativex4 sprays Sativex in fasted state on Day 1. 4 sprays Sativex in fed state on Day 4. 4 sprays Sativex daily in fasted state Days 5-13.
DRUGSativex4 sprays Sativex in fed state on Day 1. 4 sprays Sativex in fasted state on Day 4. 4 sprays Sativex daily in fasted state Days 5-13.
DRUGSativex2 sprays Sativex daily in fasted state Days 4-13.
DRUGSativex8 sprays Sativex daily in fasted state Days 4-13.

Timeline

Start date
2008-01-01
Primary completion
2008-02-01
Completion
2008-02-01
First posted
2011-03-24
Last updated
2023-04-10

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01322464. Inclusion in this directory is not an endorsement.